Technology

XOMA

$39.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.65 (+1.68%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XOMA and other stocks, options, and ETFs commission-free!

About XOMA

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA. The listed name for XOMA is XOMA Corporation Common Stock.

CEO
James R. Neal
Employees
10
Headquarters
Emeryville, California
Founded
1981
Market Cap
433.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
25.32K
High Today
$39.50
Low Today
$35.46
Open Price
$38.23
Volume
34.57K
52 Week High
$46.32
52 Week Low
$14.14

Collections

XOMA Earnings

-$0.55
-$0.30
-$0.05
$0.20
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, Pre-Market

You May Also Like

MACK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure